SCHEMBL30907302

SCHEMBL30907302

CCC(=O)c1cc(C)c(-c2cc3cnc(NC(=O)OC(C)(C)C)cc3nc2N(Cc2ccc(OC)cc2)Cc2ccc(OC)cc2)cn1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MKNK2 Q9HBH9 1/20 0.37
FGFR1 P11362 10/20 0.36
SRC P12931 1/20 0.35
ABL1 P00519 5/20 0.34
KDR P35968 6/20 0.33
FLT1 P17948 5/20 0.33
FGFR2 P21802 5/20 0.33
FGFR4 P22455 5/20 0.33
FGFR3 P22607 5/20 0.33
FLT4 P35916 5/20 0.33
KCNQ4 P56696 2/20 0.33
KCNQ5 Q9NR82 2/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
PDGFRB P09619 1/20 0.32
PDGFRA P16234 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30907657 0.85 SMN1; SMN2 (0.35) ABL1
SCHEMBL30907420 0.85 ABL1 (0.40) ABL1
SCHEMBL30907265 0.83 FGFR1 (0.40) FGFR1SRCABL1PDGFRBPDGFRA
SCHEMBL30907484 0.80 GSK3B (0.36) FGFR1SRCABL1KDRFLT1
SCHEMBL30907087 0.79 GSK3B (0.35) FGFR1SRCABL1KDRFLT1
SCHEMBL30907378 0.76 GSK3B (0.42) ABL1GSK3BDYRK1AIRAK4
SCHEMBL30907294 0.74 ABL1 (0.57) ABL1GSK3BDYRK1A
SCHEMBL30907084 0.74 GSK3B (0.36) FGFR1ABL1KDRGSK3BDYRK1A
SCHEMBL30907334 0.73 ABL1 (0.46) ABL1GSK3BDYRK1A
SCHEMBL30907335 0.73 ABL1 (0.38) FGFR1SRCABL1KDRFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024097953-A1 NAPHTHYRIDINE COMPOUNDS FOR INHIBITION OF RAF KINASES ENLIVEN INC. (US) 2024-05-10 WO disclosed